drugset / Trial / NCT07186452
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the effect of itraconazole on the pharmacokinetics of HS-20093 in patients with advanced solid tumors.
Timeline
- Start
- 2025-09-23
- Primary completion
- 2026-07-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-20093 | Other / unclassified | 8 mg/kg | Intravenous |
| Subject | Itraconazole | Small molecule | 200 mg | Oral |